(Reuters) - AtriCure Inc's Synergy Ablation System heart-rhythm device is safe and effective, but its trial size and design raise some concerns, U.S. medical device reviewers said.
The latest trial "appears to have succeeded" if all enrolled patients are considered, Food and Drug Administration researchers said in documents regarding AtriCure's device, which treats abnormal heartbeat in patients requiring...
↧